Welcome to the Home of the SSF Forum
SF Local Forum Lead
Greg Cohee, MBA
Greg Cohee is a scientist and seasoned business professional with over thirty years of pharmaceutical industry experience working across various drug development functions, including discovery, clinical operations, and program management, at both large pharmaceutical and small biotech companies. His expertise encompasses project management, portfolio and resource management, process improvement, cross-functional team collaboration, data analytics and visualization, as well as technology strategy development and implementation.
Throughout his career, Greg has leveraged his scientific knowledge and business acumen to facilitate the development and launch of commercial products, as well as help build several successful start-up companies. Over the last two decades, Greg was a Managing Partner for a successful consulting firm, while also serving as the Vice President of R&D Solutions, for an eClinical company, providing software products to support Clinical Trial Operations and Resource Demand Forecasting capabilities.
Greg received his B.S. in Chemistry and M.B.A. in Finance from Rider University and is the holder of three U.S. and one European patents. Currently, he serves on the Board of Directors for BioPharmaPM, a nonprofit organization dedicated to the strategic adaptation of project management competencies for evolving biopharma needs.
SF Local Forum Co-Lead
Sonia Pawlak
As Senior Director, Pharmaceutical Sciences Program and Alliance Management, Sonia leads program management for cross functional technical teams responsible for the development and manufacture of active pharmaceutical ingredients and drug products for innovative oncology therapies. As an alliance management leader, she is responsible for identifying, evaluating, selecting, and optimizing strategic partnerships for contract manufacturing and testing services.
Over the course of her career, Sonia has led a program management team of 20+ staff, held multiple technical roles and as a project manager led CMC programs across all development phases from pre-IND though commercialization and post approval lifecycle management. A career highlight includes program management for Veklury® the first novel covid-19 antiviral therapy developed under accelerated timelines and approved in 2020.
Sonia received her Master’s in Organic Chemistry from the University of British Colombia in Vancouver BC, her B. Sc in Organic Chemistry from the University of Massachusetts in Amherst MA and holds PMP certification from the Project Management Institute.